On Tuesday, Shares of Eli Lilly and Co (NYSE:LLY), lost -1.01% to $83.88.
Eli Lilly and Company, declared that the U.S. Food and Drug Administration (FDA) has approved Portrazza™ (necitumumab injection for intravenous use, 800 mg/50 mL), in combination with gemcitabine and cisplatin, as the first biologic for the first-line treatment of people with metastatic squamous non-small cell lung cancer (NSCLC). Portrazza is not indicated for treatment of nonsquamous NSCLC.
“We have seen advances in lung cancer in the last 20 years, but not for the initial treatment of patients battling metastatic squamous non-small cell lung cancer. This is a complex disease and there is an urgent need for effective, first-line treatments,” said Richard Gaynor, M.D., senior vice president, product development and medical affairs for Lilly Oncology. “The approval of Portrazza is an important step forward that reaffirms Lilly’s commitment to discovering new treatments that respond to the needs of individual patients.”
Portrazza has been granted Orphan Drug Designation by the FDA. Orphan drug status is given in the U.S. by the FDA’s Office of Orphan Products Development (OOPD) to medicines that demonstrate promise for the diagnosis and/or treatment of rare diseases or conditions.
Eli Lilly and Company discovers, develops, manufactures, and sells pharmaceutical products worldwide. It operates through two segments, Human Pharmaceutical Products and Animal Health Products. The company offers endocrinology products to treat diabetes; osteoporosis in postmenopausal women and men; human growth hormone deficiency and pediatric growth conditions; and testosterone deficiency.
Shares of True Car Inc (NASDAQ:TRUE), inclined 14.16% to $9.03, during its last trading session.
True Car, projects total new vehicle sales, counting fleet deliveries, will reach 1,352,500 units in November, a 3.9 percent improvement from a year ago and the highest ever for the month.
The predictable growth will push the seasonally adjusted annualized rate (SAAR) for total light vehicle sales to 18.6 million units, the strongest pace of any month so far this year and up from a 17.1 million-unit SAAR a year ago. Solid consumer demand coupled with Black Friday campaigns may boost retail sales by 3 percent to 1,157,800 units.
“This continues to be a standout year for the industry, with November sales likely setting a monthly record,” said Eric Lyman, True Car’s vice president of industry insights. “Consumers are excited about Black Friday promotions and these month-long events appear to be resonating with car buyers. Brands that advertised early, Chevrolet, Hyundai, Jeep and Ram, are predictable to outperform the industry.”
True Car, Inc. operates as an Internet-based information, technology, and communication services company. The company operates its platform on the True Car Website and TrueCar mobile applications.
Finally, Shares of Joy Global Inc. (NYSE:JOY), ended its last trade with 0.98% gain, and closed at $15.38.
Joy Global Inc., declared that it will release fourth quarter and fiscal year 2015 earnings results priority to the opening of business on Wednesday, December 16, 2015. A conference call is planned for 11:00 a.m. EST that same day to discuss the financial results.
Joy Global Inc. manufactures and services mining equipment for the extraction of coal, copper, iron ore, oil sands, gold, and other minerals. It operates in two segments, Underground Mining Machinery and Surface Mining Equipment.